The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC).
 
Di Maria Jiang
No Relationships to Disclose
 
Hao-Wen Sim
No Relationships to Disclose
 
Lillian L. Siu
Leadership - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Celgene; Merck; Pfizer
Research Funding - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; Novartis; Pfizer
 
Jeremy David Shapiro
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - novartis; pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Research Funding - roche (Inst)
 
Timothy Jay Price
Consulting or Advisory Role - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
 
Derek J. Jonker
No Relationships to Disclose
 
Christos Stelios Karapetis
Honoraria - Merck
 
Andrew Strickland
No Relationships to Disclose
 
Wenjiang Zhang
No Relationships to Disclose
 
Mark Jeffery
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Siobhan Ng
No Relationships to Disclose
 
Sabe S. Sabesan
No Relationships to Disclose
 
Jenny Shannon
No Relationships to Disclose
 
Amanda Rose Townsend
Research Funding - Amgen
 
Eric Morgen
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Eric Xueyu Chen
No Relationships to Disclose